STAGE IVB PROSTATE CANCER AJCC V8
Clinical trials for STAGE IVB PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVB PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVB PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation drug aims to slow bone tumors in advanced cancer
Disease control Not yet recruitingThis early-phase study tests a new drug (Sn-117m-DTPA) that delivers low-level radiation directly to bone tumors while being gentler on bone marrow. It is for people with prostate, breast, or lung cancer that has spread to the bones. The main goals are to find the safest dose and…
Matched conditions: STAGE IVB PROSTATE CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:10 UTC
-
Could a longer break between doses improve life for men with advanced prostate cancer?
Disease control Not yet recruitingThis study is for men with advanced, hormone-resistant prostate cancer that has spread. It tests whether giving the targeted radiation drug lutetium-177 PSMA less often, based on how the cancer responds, can improve quality of life without shortening survival. About 1,500 partici…
Matched conditions: STAGE IVB PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
Estrogen patch may ease side effects of prostate cancer treatment
Symptom relief Not yet recruitingThis study tests whether adding estrogen to standard hormone therapy can reduce hot flashes and improve quality of life for men with metastatic prostate cancer that hasn't been treated with hormones before. About 60 participants will receive either standard care or standard care …
Matched conditions: STAGE IVB PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of Washington • Aim: Symptom relief
Last updated May 26, 2026 04:37 UTC